Pharmacokinetics of Natural and Engineered Secreted Factors Delivered by Mesenchymal Stromal Cells
Open Access
- 21 February 2014
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (2), e89882
- https://doi.org/10.1371/journal.pone.0089882
Abstract
Transient cell therapy is an emerging drug class that requires new approaches for pharmacological monitoring during use. Human mesenchymal stem cells (MSCs) are a clinically-tested transient cell therapeutic that naturally secrete anti-inflammatory factors to attenuate immune-mediated diseases. MSCs were used as a proof-of-concept with the hypothesis that measuring the release of secreted factors after cell transplantation, rather than the biodistribution of the cells alone, would be an alternative monitoring tool to understand the exposure of a subject to MSCs. By comparing cellular engraftment and the associated serum concentration of secreted factors released from the graft, we observed clear differences between the pharmacokinetics of MSCs and their secreted factors. Exploration of the effects of natural or engineered secreted proteins, active cellular secretion pathways, and clearance mechanisms revealed novel aspects that affect the systemic exposure of the host to secreted factors from a cellular therapeutic. We assert that a combined consideration of cell delivery strategies and molecular pharmacokinetics can provide a more predictive model for outcomes of MSC transplantation and potentially other transient cell therapeutics.Keywords
This publication has 40 references indexed in Scilit:
- A Decade of Cell Therapy Clinical Trials (2000–2010)Regenerative Medicine, 2012
- Promising Growth and Investment in the Cell Therapy Industry during the First Quarter of 2012Cell Stem Cell, 2012
- Cell Therapy Industry: Billion Dollar Global Business with Unlimited PotentialRegenerative Medicine, 2011
- Bone Marrow-Derived Mesenchymal Stem Cells Ameliorate Autoimmune Enteropathy Independently of Regulatory T CellsThe International Journal of Cell Cloning, 2008
- Mesenchymal Stem Cells Enhance Wound Healing Through Differentiation and AngiogenesisThe International Journal of Cell Cloning, 2007
- Mesenchymal stem cells reside in virtually all post-natal organs and tissuesJournal of Cell Science, 2006
- Intravenous infusion of immortalized human mesenchymal stem cells protects against injury in a cerebral ischemia model in adult ratExperimental Neurology, 2006
- Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activationBone Marrow Transplantation, 2004
- Autologous mesenchymal stem cell transplantation induce VEGF and neovascularization in ischemic myocardiumRegulatory Peptides, 2003
- Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine HeartCell Metabolism, 2002